639P A Phase II Study of Irinotecan-Cisplatin Plus Durvalumab for Untreated Extensive-Stage Small Cell Lung Cancer (WJOG13520L, REBORN Trial)
Annals of Oncology(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined